Indication:

• Prevention of nausea and vomiting associated with highly emetogenic cancer chemotherapy
• Prevention of nausea and vomiting associated with radiotherapy
• Prevention of post-operative nausea and vomiting

Dosage & Administration:

Adult- The recommended adult oral dosage of Ondansetron is 24 mg given as three 8 mg tablets in highly emetogenic chemotherapy. In case of moderately emetogenic chemotherapy the oral dose is one 8 mg Ondansetron tablet or 10 ml of Ondansetron oral solution given twice daily.

Pediatric patients- For pediatric patients 4 through 11 years of age the dosage is one 4 mg Ondansetron tablet or 5ml of Ondansetron solution should be administered 3 times a day for 1 to 2 days after completion of chemotherapy.

Preparation:

Pukenil^® 8mg tablet: Each box contains 3x10’s tablets in blister strip

Pukenil^® syrup: Each bottle contains 50ml syrup with measuring cup